To assess the efficacy of MAGI3 in predicting recurrence in CRC patients, we plotted the receiver operating characteristic (ROC) curve with MAGI3 protein level compared with that of serum carcinoembryonic antigen (CEA) which is the most common indicator used to predict CRC recurrence [28, 29]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.